1 completed, 1 enrolling by invitation, 1 recruiting, 1 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 1, Enrolling by invitation 1, Recruiting 1, Terminated 1, Unknown 1 |
Follow Anticoagulant-induced Bleeding: new trials by email Literature Review of Anticoagulant-induced Bleeding trials Research Report on Anticoagulant-induced Bleeding
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism Rivaroxaban, Placebo - Pulmonary Embolism, Embolism | Phase 4 | Recruiting | Drahomir Aujesky | 276 | 2020-05-15 | 2026-05-22 |
| Safety of Anticoagulant Therapy After Endoscopic Treatment nadroparin calcium-warfarin sequential anticoagulation - Cirrhosis, Portal Vein Thrombosis | Phase 4 | Completed | Qilu Hospital of Shandong University | 86 | 2020-02-01 | 2022-10-12 |
| Study of Antithrombotic Treatment After IntraCerebral Haemorrhage Antithrombotic Agent - Cerebral Hemorrhage, Intracranial Hemorrhages | Phase 4 | Terminated | Oslo University Hospital | 134 | 2018-07-01 | 2025-02-12 |
| LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe - Sarcoma, Soft Tissue Sarcoma | Phase 4 | Enrolling by invitation | Massachusetts General Hospital | 2868 | 2018-02-16 | 2026-10-09 |
| Reversal of the Antithrombotic Action of New Oral Anticoagulants Rivaroxaban, Dabigatran - Thrombosis, Anticoagulant-induced Bleeding | Phase 4 | Unknown | Gines Escolar | 10 | 2012-01-01 | 2012-03-12 |
Hemorrhage (2) · Venous Thromboembolism (2) · Atrial Fibrillation (1) · Bone Neoplasms (1) · Cardiovascular Diseases (1) · Cerebral Hemorrhage (1) · Embolism (1) · Embolism and Thrombosis (1) · Esophageal and Gastric Varices (1) · Fibrosis (1) · Hematoma (1) · Intracranial Hemorrhages (1) · Lung Diseases (1) · Pulmonary Embolism (1) · Respiratory Tract Diseases (1)
Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Vascular Diseases (4) · Cardiovascular Diseases (3) · Embolism and Thrombosis (2) · Hemorrhage (2) · Thromboembolism (2) · Arrhythmias, Cardiac (1) · Bone Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Digestive System Diseases (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1)
Rivaroxaban (2) · Aspirin (1) · Dabigatran (1) · Enoxaparin (1) · Fibrinolytic Agents (1)
Drahomir Aujesky (1) · Gines Escolar (1) · Massachusetts General Hospital (1) · Oslo University Hospital (1) · Qilu Hospital of Shandong University (1)
Belgium (1) · Canada (1) · China (1) · Denmark (1) · France (1) · Netherlands (1) · Norway (1) · Spain (1) · Sweden (1) · Switzerland (1) · United States (1)
Drahomir Aujesky, Prof. MD MSc (1) · Gines Escolar, M.D., Ph.D. (1) · Santiago A Lozano-Calderon, MD, PhD (1) · Torgeir Bruun Wyller, PhD (1) · Yanjing Gao, PhD.MD (1)
PMID 26364029, PMID 33444199, PMID 34022160, PMID 34022170
2019 (1)